Jon Congleton
Board Member
Mineralys Therapeutics, Inc. (MLYS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Mineralys Therapeutics, Inc. (MLYS) | President and Chief Executive Officer | $636,500 | $5,544,727 |
| 2024 | Mineralys Therapeutics, Inc. (MLYS) | President and Chief Executive Officer | $580,000 | $5,420,868 |
| 2023 | Mineralys Therapeutics, Inc. (MLYS) | President and Chief Executive Officer | $517,000 | $5,342,057 |
| 2022 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | $416,667 | $1,740,185 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.